- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02645721
Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders (ICBT-AUD)
Internet Based Cognitive Behavior Treatment for Alcohol Use Disorders - a Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
Two Internet based programs based on cognitive behavioral therapy and relapse prevention are evaluated among Internet help seekers, and compared to a waiting list. The design is a three armed randomized controlled trial, and outcomes are measured in terms of changes in alcohol consumption (mean consumption/week, number of heavy drinking days/week), problematic alcohol use, self efficacy, craving, as well as depression, anxiety and quality of life. In addition to this, the following instruments will be used as predictors: ASRS (ADHD), Hp5i (personality assessment). TIC-P, an instrument measuring cost effectiveness will also be used. Treatment Credibility and Adverse Events will also be assessed, the former once during the third week of treatment, and the latter once half way through treatment and once after treatment.
Primary hypothesis is that the more extended program with guidance (group 1) is more effective in reducing mean alcohol consumption and number of heavy drinking days compared to the briefer program with no guidance (group 2), as well as compared to a waiting list (group 3). A responder to treatment is defined as a participant drinking less than 9 (women)/ 14(men) glasses per week and no more than 3 (women)/4 (men) glasses per drinking day during that week.
A minimum of 169 participants will be recruited in two phases: first through an online screening and then through a diagnostic telephone assessment, where SCID will be used to diagnose Alcohol Use Disorders and MINI will be used to diagnose other psychiatric diagnoses. The telephone assessment and all guidance will be conducted by licensed psychologists or master students in psychology under supervision by licensed psychologists.
Included participants will be randomized into three groups:
Group 1: All participants in this group will have access to an extended cognitive behavioral treatment program and have access to a guide with basic training in psychotherapy (CBT) who assists and counsels the participant throughout the program.
Group 2: Participants in this group will have access to a briefer cognitive behavior treatment program with no access to a guide.
Group 3: Participants in this group will be placed on a waiting list for 12 weeks. Thereafter, they will be given access to the same extended cognitive behavior treatment program as Group 1; they will also be offered a possibility to choose between three guidance options: Choice 1: guide with intensive support, Choice 2: guide with support only at request, Choice 3: no guide.
Interim analyses will be undertaken in May 2016 by graduate students in Clinical psychology writing their MSc theses.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 11364
- Karolinska Institutet
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ≥ 18 years
- access to the internet
- consumption of at least 9 (females)/14 (males) glasses of alcohol during the preceding week
- AUDIT ≥ 14 for females, ≥ 16 for men
- have an Alcohol Use Disorder according to the DSM-5 (i.e., at least 2 out of 11 criteria)
Exclusion Criteria:
- insufficient Swedish skills
- reading or writing difficulties, if it is to a degree that it will hamper the treatment
- concurrent other psychological treatment with a content resembling treatments in this study
- severe depression defined as a score of more than 30 on the MADRS-S
- suicide-risk defined as more than 4 points on the MADRS-S question 9, or based on the structured interview
- Drug use problems defined as ≥ 8 p on the DUDIT
- somatic or psychiatric disorders that are contraindicated for the treatment or impairs the ability to receive it (for example schizophrenia, bipolar disease, PTSD)
- has during the last 3 weeks begun medication for alcohol problems or other psychiatric disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Extended self-help program with guidance
The program is a comprehensive CBT program lasting 12 weeks, with as many modules.
The modules are quite extensive.
A guide with basic education in psychotherapy assists and counsels participants online.
|
See arm description for Experimental
Other Names:
|
|
Active Comparator: Briefer Self-help program, no guidance
This self-help program also lasts 12 weeks but contains only 9 modules; a pause occurs during the final weeks of the program for self-testing of acquired skills.
The modules are quite brief.
Participants receive no guidance.
|
See arm description for Active Comparator
Other Names:
|
|
Other: WL: Extended self-help program, choice of guidance intensity
Participants will be put on a waiting list.
After 12 weeks on the waiting list, participants will receive access the the extended self-help program used in the experimental arm.
However, participants will be offered a choice between three guidance options of varying intensity: proactive guidance, reactive guidance (only at participant request) or no guidance.
|
See arm description for Waiting list.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time Line Follow Back
Time Frame: Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
|
Number of standard drinks during preceding week (using the Time Line Follow Back)
|
Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
|
|
Time Line Follow Back
Time Frame: Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
|
Days of heavy drinking during preceding week (using the Time Line Follow Back)
|
Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol Use Disorders Identification Test
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
assessement of alcohol use problems
|
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
|
Alcohol Abstinence Self Efficacy Scale
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
instrument measuring self-efficacy
|
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
|
Penn Alcohol Craving Scale
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
instrument measuring craving for alcohol
|
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
|
Montgomery Asberg Depression Rating Scale
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
instrument measuring depression
|
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
|
Euro-QOL 5 D
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
instrument measuring quality of life
|
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
|
Generalized Anxiety Disorder-7
Time Frame: Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
instrument measuring anxiety
|
Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
|
|
Trimbos and iMTA questionnaire on cCosts associated with Psychiatric illness (TiC-P)
Time Frame: Screening, 12 months, 24 months post-treatment
|
Instrument measuring health care consumption and cost-effectiveness (Bouwmans et al., 2013
|
Screening, 12 months, 24 months post-treatment
|
|
Self-report questionnnaire on satisfaction with internet treatment usability features
Time Frame: Post-treatment (12 weeks after before-treatment measure)
|
This instrument contains 40 questions about satisfaction with various features of the internet-based treatment.
Results will be analyzed on an aggregated group level.
The questionnaire was constructed by the Internet psychiatry clinic in Stockholm.
|
Post-treatment (12 weeks after before-treatment measure)
|
|
Adult ADHD Self Report Scale (ASRS)
Time Frame: Screening
|
Screening of ADHD symptoms to be used as predictor of treatment outcome
|
Screening
|
|
Health-relevant Personality traits from a Five-factor perspective (hp5i)
Time Frame: Screening
|
Screening of personality traits to be used as predictor of treatment outcome
|
Screening
|
|
Adverse Events
Time Frame: Halfway through treatment (6 weeks after before-treatment measure) and post-treatment (12 weeks after before-treatment measure)
|
Brief questionnaire with questions about any negative side effects of the treatment
|
Halfway through treatment (6 weeks after before-treatment measure) and post-treatment (12 weeks after before-treatment measure)
|
|
Treatment Credibility Scale
Time Frame: 3 weeks after before-treatment measure
|
Brief questionnaire about if the treatment this far is perceived as effective
|
3 weeks after before-treatment measure
|
|
SCID- section of Alcohol Use Disorders (adjusted to DSM5)
Time Frame: Screening interview, 12 and 24 months post-treatment
|
Diagnostic interview via telephone, diagnostic criteria of Alcohol Use Disorders (this will be undertaken if resurces allow).
This will be a masked assessment, the interviewer will not know which original group the participant was randomized to
|
Screening interview, 12 and 24 months post-treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Anne H Berman, PhD, Karolinska Institutet
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015/2014-31
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorders
-
University of Colorado, DenverUnknownAlcohol Use Disorders | Unhealthy Alcohol UseUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
Clinical Trials on Extended self-help program with guidance
-
University of ReginaCanadian Institutes of Health Research (CIHR); University of Calgary; Saskatchewan...Not yet recruitingInfertility | Distress, Emotional | Mental Health IssueCanada
-
Stockholm UniversityCompletedSocial Anxiety DisorderSweden
-
Stanford UniversityNational Institute of Mental Health and Neuro Sciences, IndiaCompleted
-
Uppsala UniversityWithdrawnDepression | Cancer | AnxietySweden
-
Merja NikulaHelsinki University Central Hospital; University of Helsinki; University of Oulu and other collaboratorsRecruiting
-
Merja NikulaHelsinki University Central Hospital; University of Helsinki; University of Oulu and other collaboratorsRecruitingAttention Deficit Hyperactivity DisorderFinland
-
University of BernUniversity of ZurichCompleted
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
University of BernCompletedSelf-criticismSwitzerland
-
University of NottinghamUnknownCarer Stress SyndromeUnited Kingdom